Table of Content

1 Product Definition

2 Scope of Research Study
2.1 Key Questions Answered in the Report
2.2 Forecast Period Selection Criteria

3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
3.3 Data Sources and Categorization
3.4 Market Estimation and Forecast Methodology
3.5 Data Triangulation

4 Competitive Landscape
4.1 Key Developments and Strategies
4.1.1 Regulatory and Legal
4.1.2 New Offerings
4.1.3 Partnerships, Alliances, and Business Expansions
4.1.4 Mergers and Acquisitions
4.1.5 Funding Activities
4.2 Market Share Analysis
4.2.1 Company
4.2.2 Neuromicroscopy
4.2.3 Neuronavigation
4.2.4 Neuroendoscopy
4.2.5 Neurosurgical Robotics
4.3 Growth Share Analysis
4.3.1 Product Type
4.3.2 Region

5 Industry Insights
5.1 Legal Regulations
5.1.1 U.S.
5.1.2 European Union (EU)
5.1.3 China
5.1.4 Japan
5.2 Impact of COVID-19
5.3 Awaited Technological Developments
5.3.1 Age of Augmented Reality (AR) Integration
5.4 Patent Analysis
5.4.1 Patent Filing Trends
5.4.2 Patent Filing Trend (by Product Type)
5.4.3 Patent Filing Trend (by Country)
5.4.4 Impact of Patent Expiration
5.5 Minimally Invasive Surgeries: Opportunity Analysis
5.5.1 Pre-COVID-19 Scenario
5.5.2 Post-COVID-19 Scenario

6 Market Dynamics
6.1 Impact Analysis
6.2 Market Drivers
6.2.1 Increasing Elderly Population on the Global Level Propels the Demand for Minimally Invasive Neurosurgical Procedures
6.2.2 Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
6.2.3 Availability of Technological Advanced Products in the Field of Neurosurgical Procedures
6.3 Market Restraints
6.3.1 Lack of Skilled Professionals
6.3.2 Restrictive Reimbursement Framework
6.4 Market Opportunities
6.4.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
6.4.1.1 Advantages of Long-Distance Teleoperated Surgical Robotics

7 Global Minimally Invasive Neurosurgical Systems Market Scenario
7.1 Global Market Outlook, 2019-2030
7.2 Key Findings
7.3 Assumptions and Limitations

8 Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
8.1 Market Overview
8.2 Neuromicroscopy
8.2.1 Overview
8.2.2 Market Size and Forecast
8.3 Neuronavigation
8.3.1 Overview
8.3.2 Market Size and Forecast
8.3.3 Optical Neuronavigation Systems
8.3.4 Electromagnetic Neuronavigation Systems
8.4 Neuroendoscopy
8.4.1 Overview
8.4.2 Market Size and Forecast
8.4.3 Rigid Neuroendoscopy Systems
8.4.4 Flexible Neuroendoscopy Systems
8.5 Neurosurgical Robotics
8.5.1 Overview
8.5.2 Market Size and Forecast
8.5.3 Systems (Capital Equipment)
8.5.4 Instruments and Accessories
8.5.5 Services

9 Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019-2030
9.1 Market Overview
9.2 North America
9.2.1 Opportunity Assessment
9.2.2 Market Size and Forecast
9.2.3 U.S.
9.2.4 Canada
9.3 Europe
9.3.1 Opportunity Assessment
9.3.2 Market Size and Forecast
9.3.3 Germany
9.3.4 France
9.3.5 U.K.
9.3.6 Italy
9.3.7 Spain
9.3.8 Netherlands
9.3.9 Switzerland
9.3.10 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Opportunity Assessment
9.4.2 Market Size and Forecast
9.4.3 Japan
9.4.4 China
9.4.5 South Korea
9.4.6 India
9.4.7 Australia and New Zealand
9.4.8 Singapore
9.4.9 Rest-of-Asia-Pacific
9.5 Rest-of-the-World (Latin America and Middle East and Africa)
9.5.1 Opportunity Assessment
9.5.2 Market Size and Forecast

10 Company Profiles
10.1 Overview
10.2 Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
10.2.1 Company Overview
10.2.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.2.3 Financials
10.2.4 SWOT Analysis
10.3 Microbot Medical, Inc.
10.3.1 Company Overview
10.3.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.3.3 SWOT Analysis
10.4 Synaptive Medical, Inc.
10.4.1 Company Overview
10.4.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.4.3 SWOT Analysis
10.5 Stryker Corporation
10.5.1 Company Overview
10.5.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.5.3 Financials
10.5.4 SWOT Analysis
10.6 Zimmer Biomet Holdings, Inc.
10.6.1 Company Overview
10.6.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 B. Braun Melsungen AG
10.7.1 Company Overview
10.7.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 Olympus Corporation
10.8.1 Company Overview
10.8.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.8.3 Financials
10.8.4 SWOT Analysis
10.9 Renishaw plc
10.9.1 Company Overview
10.9.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.9.3 Financials
10.9.4 SWOT Analysis
10.1 Medtronic plc
10.10.1 Company Overview
10.10.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.10.3 Financials
10.10.4 SWOT Analysis
10.11 Leica Microsystems (Danaher Corporation)
10.11.1 Company Overview
10.11.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12 Carl Zeiss AG
10.12.1 Company Overview
10.12.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.12.3 Financials
10.12.4 SWOT Analysis
10.13 Haag-Streit Holding AG (Metall Zug AG)
10.13.1 Company Overview
10.13.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 Karl Storz SE & Co. KG
10.14.1 Company Overview
10.14.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.14.3 SWOT Analysis
10.15 Brainlab AG
10.15.1 Company Overview
10.15.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.15.3 SWOT Analysis
10.16 Monteris Medical Corporation
10.16.1 Company Overview
10.16.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
10.16.3 SWOT Analysis
List of Tables
Table 1: Impact of Market Drivers
Table 2: Impact of Market Restraints
Table 5.1: Minimally Invasive Neurosurgical Systems: FDA Product Classification
Table 6.1: Impact Analysis: Market Drivers
Table 6.2: Impact Analysis: Market Restraints
Table 9.1: North America Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.2: U.S. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.3: Canada Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.4: Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.5: Germany Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.6: France Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.7: U.K. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.8: Italy Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.9: Spain Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.10: Netherlands Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.11: Switzerland Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.12: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.13: Asia-Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.14: Japan Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.15: China Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.16: South Korea Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.17: India Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.18: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.19: Singapore Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.20: Rest-of-Asia Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
Table 9.21: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
List of Figures
Figure 1: Evolution of Surgery
Figure 2: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 3: Company Share Analysis, 2019
Figure 4: Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019 and 2030
Figure 5: Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019, 2025, and 2030
Figure 6: Global Minimally Invasive Neurosurgical Systems Market Growth (by Region), 2019, 2025, and 2030
Figure 7: Key Strategies Incorporated by the Key Players (January 2015–August 2020)
Figure 3.1: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-Up Approach
Figure 4.1: Share of Key Developments and Strategies (by Category), January 2015-August 2020
Figure 4.2: Number of Key Developments and Strategies (by Year), January 2015–August 2020
Figure 4.3: Number of Key Developments and Strategies (by Regulatory and Legal Activities), January 2015–August 2020
Figure 4.4: Number of Key Developments and Strategies (by New Offerings), January 2015–August 2020
Figure 4.5: Market Share Analysis (by Company), 2019
Figure 4.6: Growth Share Analysis (by Product Type), 2019-2030
Figure 4.7: Growth Share Analysis (by Region), 2019-2030
Figure 5.1: Regulatory Process for Medical Devices in the U.S.
Figure 5.2: MDR Transitional Provisions (EU)
Figure 5.3: Timeline and Impact of MDR (EU)
Figure 5.4: Regulatory Process for Medical Devices in European Union
Figure 5.5: Regulatory Process for Medical Devices in the China
Figure 5.6: Regulatory Process for Medical Devices in Japan
Figure 5.7: Patent Filing Trend (by Year), January 2015–September 2020
Figure 5.8: Percentage of Patent Filed in Different Technological Area, (January 2015–September 2020
Figure 5.9: Patent Filing Trend (by Year), January 2015–September 2020
Figure 5.10: Minimally Invasive Surgery – Pre-COVID-19 Scenario
Figure 5.11: Number of Elective Surgical Procedures Cancelled due to COVID?19 (by Region)
Figure 6.1: Market Dynamics
Figure 6.2: Global Prevalence of Neurological Disorders (by Age-Group), 2013-2017
Figure 6.3: Global Deaths due to Neurological Disorders (by Age-Group), 2013-2017
Figure 6.4: Advantages of Minimally Invasive Surgical Procedures
Figure 6.5: Overview of Telesurgery Workflow
Figure 6.6: Telesurgery: Bridging the Gap Associated with Healthcare Accessibility
Figure 7.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 7.2: Global Market Incremental Revenue Opportunity Analysis, 2019-2030
Figure 8.1: Global Minimally Invasive Neurosurgical Systems Market (by Product Type)
Figure 8.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Product Type), 2019 and 2030
Figure 8.3: Global Neuromicroscopy Market, 2019-2030
Figure 8.4: Market Segmentation:
Figure 8.5: Global Neuronavigation Market, 2019-2030
Figure 8.6: Global Neuronavigation Market Share, 2019 and 2030
Figure 8.7: Global Optical Neuronavigation Systems Market, 2019-2030
Figure 8.8: Global Electromagnetic Neuronavigation Systems Market, 2019-2030
Figure 8.9: Market Potential of Endoscopy Systems (by Application)
Figure 8.10: Market Segmentation:
Figure 8.11: Global Neuroendoscopy Market, 2019-2030
Figure 8.12: Global Neuroendoscopy Market Share, 2019 and 2030
Figure 8.13: Global Rigid Neuroendoscopy Systems Market, 2019-2030
Figure 8.14: Global Flexible Neuroendoscopy Systems Market, 2019-2030
Figure 8.15: Market Segmentation:
Figure 8.16: Global Neurosurgical Robotics Market, 2019-2030
Figure 8.17: Global Neurosurgical Robotics Market Share, 2019 and 2030
Figure 8.18: Global Neurosurgical Robotics Market (by System), 2019-2030
Figure 8.19: Global Neurosurgical Robotics Market (Instruments and Accessories), 2019-2030
Figure 8.20: Global Neurosurgical Robotics Market (by Service), 2019-2030
Figure 9.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Region), 2019 and 2030
Figure 9.3: North America: Incremental Revenue Opportunity, 2019-2030
Figure 9.4: North America Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.5: North America Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
Figure 9.6: U.S. Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.7: Canada Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.8: Europe: Incremental Revenue Opportunity, 2019-2030
Figure 9.9: Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.10: Europe Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
Figure 9.11: Germany Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.12: France Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.13: U.K. Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.14: Italy Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.15: Spain Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.16: Netherlands Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.17: Switzerland Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.18: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.19: Asia-Pacific: Incremental Revenue Opportunity, 2019-2030
Figure 9.20: Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.21: Asia-Pacific Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
Figure 9.22: Japan Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.23: China Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.24: South Korea Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.25: India Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.26: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.27: Singapore Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.28: Rest-of-Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 9.29: Rest-of-the-World: Incremental Revenue Opportunity, 2019-2030
Figure 9.30: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market, 2019-2030
Figure 10.1: Global Minimally Invasive Neurosurgical Systems Market: Key Companies
Figure 10.2: Corindus Vascular Robotics, Inc.: Overall Financials ($Million), 2016-2018
Figure 10.3: Corindus Vascular Robotics, Inc.: Net Revenue (by Segment), 2016-2018
Figure 10.4: Corindus Vascular Robotics, Inc.: Net Revenue (by Region), 2016-2018
Figure 10.5: Stryker Corporation: Overall Financials ($Million), 2017-2019
Figure 10.6: Stryker Corporation: Net Revenue (by Segment), 2017-2019
Figure 10.7: Stryker Corporation: Net Revenue (by Region), 2017-2019
Figure 10.8: Zimmer Biomet Holdings, Inc.: Overall Financials ($Million), 2017-2019
Figure 10.9: Zimmer Biomet Holdings, Inc.: Net Revenue (by Product Category), 2017-2019
Figure 10.10: Stryker Corporation: Net Revenue (by Region), 2017-2019
Figure 10.11: B. Braun Melsungen AG: Overall Financials ($Million), 2017-2019
Figure 10.12: B. Braun Melsungen AG: Net Revenue (by Segment), 2017-2019
Figure 10.13: B. Braun Melsungen AG: Net Revenue (by Region), 2017-2019
Figure 10.14: Olympus Corporation: Overall Financials ($Million), 2018-2020
Figure 10.15: Olympus Corporation: Net Revenue (by Segment), 2018-2020
Figure 10.16: Olympus Corporation: Net Revenue (by Region), 2018-2020
Figure 10.17: Renishaw plc: Overall Financials ($Million), 2018-2020
Figure 10.18: Renishaw plc: Net Revenue (by Segment), 2018-2020
Figure 10.19: Renishaw plc: Net Revenue (by Region), 2018-2020
Figure 10.20: Medtronic plc: Overall Financials ($Million), 2018-2020
Figure 10.21: Medtronic plc: Net Revenue (by Segment), 2018-2020
Figure 10.22: Medtronic plc: Net Revenue (by Region), 2018-2020
Figure 10.23: Danaher Corporation: Overall Financials ($Million), 2017-2019
Figure 10.24: Danaher Corporation: Net Revenue (by Segment), 2017-2019
Figure 10.25: Danaher Corporation: Net Revenue (by Region), 2018-2019
Figure 10.26: Carl Zeiss AG: Overall Financials ($Million), 2017-2019
Figure 10.27: Carl Zeiss AG: Net Revenue (by Segment), 2017-2019
Figure 10.28: Carl Zeiss AG: Net Revenue (by Region), 2018-2019
Figure 10.29: Metall Zug AG: Overall Financials ($Million), 2017-2019
Figure 10.30: Metall Zug AG: Net Revenue (by Segment), 2017-2019
Figure 10.31: Metall Zug AG: Net Revenue (by Region), 2018-2019